Digital Cell Morphology System Market Report 2025

The digital cell morphology system market size has grown rapidly in recent years. It will grow from $1.89 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth during the historic period can be attributed to the increasing adoption of hematology analyzers, the growing need for efficient laboratory workflows, rising awareness of early disease detection, the escalating prevalence of infectious and chronic diseases, and the demand for standardized diagnostic procedures.

The digital cell morphology system market size is expected to see rapid growth in the next few years. It will grow to $3.16 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth during the forecast period can be attributed to the increasing prevalence of hematological disorders, growing demand for laboratory automation, the need for remote and digital pathology solutions, an expanding geriatric population, and the development of healthcare infrastructure. Key trends in this period include the integration of artificial intelligence for automated cell classification, the development of high-speed image processing algorithms, integration with laboratory information systems, the use of machine learning for predictive diagnostics, miniaturization of imaging hardware, and the development of multi-modal imaging platforms.

The rising prevalence of hematological disorders is expected to drive growth in the digital cell morphology system market. Hematological disorders, including anemia, leukemia, and clotting disorders, affect the blood, bone marrow, and lymphatic system. Their increasing occurrence is linked to the rising prevalence of chronic diseases, which impact blood health and require continuous monitoring. Digital cell morphology systems support the diagnosis of these disorders by providing precise, automated blood cell image analysis for accurate classification. They enhance laboratory efficiency by reducing manual review, improving consistency, and enabling faster clinical decision-making. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit, reported that the number of people with hemophilia reached 257,146 in 2022, up from 233,577 in 2021. This growing prevalence is therefore fueling the digital cell morphology system market.

Companies in this market are developing AI-driven image analyzers to improve diagnostic speed and accuracy. AI-driven image analyzers use artificial intelligence to automatically interpret digital images, enhancing analysis consistency and precision. In July 2025, Scopio Labs Ltd., an Israel-based medical equipment company, launched the complete blood morphology (CBM) analyzer, an automated AI-driven image analyzer for peripheral blood smear review. The CBM analyzer employs full-field imaging to autonomously process and evaluate up to ten times more cells than traditional methods. It also enables the development of new morphology-based biomarkers and diagnostic panels, supporting earlier disease detection and real-time patient monitoring. This innovation addresses challenges such as global shortages of trained laboratory technologists, variability in manual interpretations, and increasing diagnostic demand.

In March 2022, Axion BioSystems Inc., a US-based life sciences tools company, acquired CytoSMART Technologies B.V. for an undisclosed amount. Through this acquisition, Axion aims to enhance live-cell imaging and analysis capabilities, strengthen its presence in stem cell research, immuno-oncology, cell-based therapies, and drug discovery, and provide researchers with advanced, real-time, noninvasive cellular analysis tools. CytoSMART Technologies B.V., based in the Netherlands, specializes in digital cell morphology systems.

Major players in the digital cell morphology system market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Mindray Medical International Limited, Nikon Corporation, IDEXX Laboratories Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Leica Microsystems GmbH, Medica Corporation, Scopio Labs Ltd., MetaSystems Hard & Software GmbH, West Medica Produktions- und Handels-GmbH, ZhiWei Information & Technology Co. Ltd.

North America was the largest region in the digital cell morphology system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital cell morphology system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the digital cell morphology system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A digital cell morphology system is a sophisticated laboratory diagnostic tool designed to capture, analyze, and store high-resolution digital images of blood and body fluid cells. It automates the microscopic examination process, allowing for precise cell identification and classification. The system’s primary goal is to enhance diagnostic efficiency, standardize results, and facilitate timely detection of hematological disorders.

The main categories of digital cell morphology systems include cell imaging systems, cell analysis systems, and accessories and consumables. Cell imaging systems are devices that capture high-resolution digital images of cells using microscopes and cameras, often incorporating AI for automated analysis. These systems employ technologies such as microscopy, flow cytometry, and image processing software and are distributed through direct sales, distributors, and online channels. They find applications in hematology, oncology, infectious diseases, and other fields, serving end users including academic and research institutes, hospitals and clinical laboratories, and biotechnology and pharmaceutical companies.

The digital cell morphology system market research report is one of a series of new reports that provides digital cell morphology system market statistics, including digital cell morphology system industry global market size, regional shares, competitors with the digital cell morphology system market share, digital cell morphology system market segments, market trends, and opportunities, and any further data you may need to thrive in the digital cell morphology system industry. This digital cell morphology system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital cell morphology system market consists of revenues earned by entities by providing services such as digital imaging and analysis of blood and cellular samples, automated cell counting and classification, remote diagnostic consultations, and software integration for laboratory information systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital cell morphology system market also includes sales of automated hematology analyzers, microscopy imaging software, sample preparation kits, data management and analysis platforms, and related hardware components. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.